Columbia Advisory Partners’s Adaptimmune Therapeutics ADAP Stock Holding History

Columbia Advisory Partners’s Portfolio ADAP Stock Details ADAP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$4.78K	Hold
2025 Q2	$8.8K	Buy
2025 Q1	$7.2K	Buy
2024 Q4	$8.85K	Sell
2024 Q3	$29.9K	Buy
2024 Q2	$27.4K	Buy
2024 Q1	$24.6K	Buy